Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada.
Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, M5T 1R8, Canada.
Hum Brain Mapp. 2017 Nov;38(11):5519-5534. doi: 10.1002/hbm.23744. Epub 2017 Jul 28.
Abnormalities in dopamine (DA) and brain morphology are observed in several neuropsychiatric disorders. However, it is not fully understood how these abnormalities may relate to one another. For such in vivo findings to be used as biomarkers for neuropsychiatric disease, it must be understood how variability in DA relates to brain structure under healthy conditions. We explored how the availability of striatal DA D receptors (D R) is related to the volume of subcortical brain structures in a sample of healthy humans. Differences in D R availability measured with an antagonist radiotracer ([ C]-raclopride) versus an agonist radiotracer ([ C]-(+)-PHNO) were examined.
Data from 62 subjects scanned with [ C]-raclopride (mean age = 38.98 ± 14.45; 23 female) and 68 subjects scanned with [ C]-(+)-PHNO (mean age = 38.54 ± 14.59; 25 female) were used. Subcortical volumes were extracted from T1-weighted images using the Multiple Automatically Generated Templates (MAGeT-Brain) algorithm. Partial correlations were used controlling for age, gender, and total brain volume.
For [ C]-(+)-PHNO, ventral caudate volumes were positively correlated with BP in the dorsal caudate and globus pallidus (GP). Ventral striatum (VS) volumes were positively correlated with BP in the VS. With [ C]-raclopride, BP in the VS was negatively correlated with subiculum volume of the hippocampus. Moreover, BP in the GP was negatively correlated with the volume of the lateral posterior nucleus of the thalamus.
Findings are purely exploratory and presented corrected and uncorrected for multiple comparisons. We hope they will help inform the interpretation of future PET studies where concurrent changes in D R and brain morphology are observed. Hum Brain Mapp 38:5519-5534, 2017. © 2017 Wiley Periodicals, Inc.
多巴胺(DA)和脑形态的异常在几种神经精神疾病中都有观察到。然而,这些异常如何相互关联还不完全清楚。为了将这些体内发现用作神经精神疾病的生物标志物,必须了解 DA 的可变性在健康条件下与脑结构的关系。我们在一组健康人群中探讨了纹状体 DA D 受体(D R)的可利用性与皮质下脑结构体积之间的关系。使用拮抗剂放射性示踪剂([ C]-raclopride)与激动剂放射性示踪剂([ C]-(+)-PHNO)测量的 D R 可利用性的差异进行了研究。
使用 [ C]-raclopride(平均年龄=38.98±14.45;23 名女性)和 [ C]-(+)-PHNO(平均年龄=38.54±14.59;25 名女性)扫描的 62 名受试者和 68 名受试者的数据。使用多自动生成模板(MAGeT-Brain)算法从 T1 加权图像中提取皮质下体积。使用偏相关,控制年龄、性别和总脑容量。
对于 [ C]-(+)-PHNO,腹侧尾状核体积与背侧尾状核和苍白球(GP)中的 BP 呈正相关。腹侧纹状体(VS)体积与 VS 中的 BP 呈正相关。使用 [ C]-raclopride,VS 中的 BP 与海马的下托体积呈负相关。此外,GP 中的 BP 与丘脑外侧后核的体积呈负相关。
这些发现纯粹是探索性的,并且经过了校正和未校正的多重比较。我们希望它们将有助于解释未来的 PET 研究,这些研究观察到 D R 和脑形态的同时变化。人类大脑映射 38:5519-5534,2017。© 2017 Wiley Periodicals,Inc.